Now showing items 1-1 of 1

    • Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway 

      Petiti, Juan Pablo; Sosa, Liliana del Valle; Picech, Florencia; Moyano Crespo, Gabriela Deisi; Arevalo Rojas, Jean Zeander; Pérez, Pablo Anibal; Guido, Carolina Beatríz; Leimgruber, Carolina; Sabatino, María Eugenia; García, Pedro; Bengió, Verónica; Papalini, Francisco Roque; Estario, Paula; Berhard, Celina; Villareal, Marcos; Gutiérrez, Silvina; De Paul, Ana Lucía; Mukdsi, Jorge Humberto; Torres, Alicia Inés (Society for Endocrinology, 2018)
      In pituitary adenomas, early recurrences and resistance to conventional pharmacotherapies are common, but the mechanisms involved are still not understood. The high expression of epidermal growth factor receptor 2 ...